Type B3 Thymoma With a Novel KMT2A::MAML3 Fusion: Expanding the Spectrum of Gene Fusions Beyond the MAML2 Gene
Sign Up to like & getrecommendations! Published in 2025 at "Genes"
DOI: 10.1002/gcc.70071
Abstract: Mastermind‐like transcriptional coactivator (MAML) gene fusions have been documented in Thymic Epithelial Tumors (TETs). Specifically, lysine methyltransferase 2A (KMT2A)::MAML2 gene fusions are associated with type B2 and B3 thymomas. Here, we report for the first… read more here.
Keywords: thymoma; fusion; maml3; gene fusions ... See more keywords
Prognostic markers in pheochromocytomas/paragangliomas: the role of histopathology, SDHB, MAML3 and MCM6 expression
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-025-02610-8
Abstract: There are currently no definitive prognostic markers that accurately predict malignant behavior in pheochromocytoma/paraganglioma (PCC/PGL). While metastasis develops in only 10–15% of adrenal-origin, this rate can rise up to 50% in those with extra-adrenal localization.… read more here.
Keywords: prognostic markers; maml3; histopathology; metastasis ... See more keywords